Showing results (311-320 of 364) with videos related to

Sort By:
Pageof 37
La Nouvelle Presse Medicale|March 8, 1975
[Chemotherapeutic combinations of mutually potentiating drugs. 3-Application to primary tumors of the central nervous system]P Pouillart, L Schwarzenberg, J L Amiel, et al.
Anticancer Research|March 1, 1983
Doxorubicin, vincristine, bleomycin, cytembena and cisplatin as combination chemotherapy for squamous cell lung cancerV Georgoulias, J L Misset, P Ribaud, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1986
An oriented phase II trial of THP-adriamycin in breast carcinomaG Mathé, H Umezawa, S Oka, et al.
La Nouvelle Presse Medicale|April 17, 1976
[Correlation between immunological stage and response to chemotherapy. Results in 64 patients with nonresectable epidermoid bronchial cancers]P Pouillart, G Botto, H Gauthier, et al.
La Nouvelle Presse Medicale|October 9, 1976
[Combination chemotherapy in the treatment of polymetastic breast cancer. Comparison of therapeutic effects of 2 methods of sequential drug administration. Role of adriamycin in these combinations]P Pouillart, L Schwarzenberg, T Palangie, et al.
Journal of the National Cancer Institute|June 20, 1990
Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rateJ P Caussanel, F Lévi, S Brienza, et al.
British Medical Journal|April 18, 1970
Bone marrow graft in man after conditioning by antilymphocytic serumG Mathé, J L Amiel, L Schwarzenberg, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1986
A phase I trial of trans-1-diaminocyclohexane oxalato-platinum (l-OHP)G Mathé, Y Kidani, K Triana, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopeciaG Mathé, M Bayssas, J Gouveia, et al.
La Nouvelle Presse Medicale|June 19, 1976
[Trial treatment of glioblastomas in adults and cerebral metastais by adriamycin, VM 26 and CCNU combination. Result of a type II trial]P Pouillart, G Mathé, M Poisson, et al.
Pageof 37